Virginia Man-Yee Lee, PhD, MBA - Related publications
Affiliations: | Pathology | University of Pennsylvania, Philadelphia, PA, United States |
Area:
tau, dementia, neurodegenerationWebsite:
http://www.med.upenn.edu/cndr/VMYLeebio.shtml
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
19 most relevant papers in past 60 days:
19 most relevant papers in past 60 days:
Year | Citation | Score | |
---|---|---|---|
2021 | Zhang G, Wu J, Huang C, Cheng J, Su Z, Zhu Z, Yang X, Guo B, Wu L, Zhang Z, Zhang G, Chen H, Sun Y, Wang Y. The Tetramethylpyrazine Analogue T-006 Alleviates Cognitive Deficits by Inhibition of Tau Expression and Phosphorylation in Transgenic Mice Modeling Alzheimer's Disease. Journal of Molecular Neuroscience : Mn. PMID 33403592 DOI: 10.1007/s12031-020-01762-x | ||
2021 | Di J, Siddique I, Li Z, Malki G, Hornung S, Dutta S, Hurst I, Ishaaya E, Wang A, Tu S, Boghos A, Ericsson I, Klärner FG, Schrader T, Bitan G. The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice. Alzheimer's Research & Therapy. 13: 6. PMID 33397489 DOI: 10.1186/s13195-020-00743-x | ||
2021 | Xu H, O'Reilly M, Gibbons GS, Changolkar L, McBride JD, Riddle DM, Zhang B, Stieber A, Nirschl J, Kim SJ, Hoxha KH, Brunden KR, Schellenberg GD, Trojanowski JQ, Lee VM. In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics. Acta Neuropathologica. PMID 33385254 DOI: 10.1007/s00401-020-02253-4 | ||
2021 | Takaichi Y, Chambers JK, Takahashi K, Soeda Y, Koike R, Katsumata E, Kita C, Matsuda F, Haritani M, Takashima A, Nakayama H, Uchida K. Amyloid β and tau pathology in brains of aged pinniped species (sea lion, seal, and walrus). Acta Neuropathologica Communications. 9: 10. PMID 33413691 DOI: 10.1186/s40478-020-01104-3 | ||
2021 | Park JE, Lim DS, Cho YH, Choi KY, Lee JJ, Kim BC, Lee KH, Lee JS. Plasma contact factors as novel biomarkers for diagnosing Alzheimer's disease. Biomarker Research. 9: 5. PMID 33422144 DOI: 10.1186/s40364-020-00258-5 | ||
2021 | Schmidt MF, Gan ZY, Komander D, Dewson G. Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities. Cell Death and Differentiation. PMID 33414510 DOI: 10.1038/s41418-020-00706-7 | ||
2021 | Polanco JC, Hand GR, Briner A, Li C, Götz J. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathologica. PMID 33417012 DOI: 10.1007/s00401-020-02254-3 | ||
2021 | Park JC, Jung KS, Kim J, Jang JS, Kwon S, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition. Alzheimer's Research & Therapy. 13: 12. PMID 33407839 DOI: 10.1186/s13195-020-00751-x | ||
2021 | Sobue A, Komine O, Hara Y, Endo F, Mizoguchi H, Watanabe S, Murayama S, Saito T, Saido TC, Sahara N, Higuchi M, Ogi T, Yamanaka K. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease. Acta Neuropathologica Communications. 9: 1. PMID 33402227 DOI: 10.1186/s40478-020-01099-x | ||
2021 | Duits FH, Wesenhagen KEJ, Ekblad L, Wolters E, Willemse EAJ, , Scheltens P, van der Flier WM, Teunissen CE, Visser PJ, Tijms BM. Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts. Alzheimer's Research & Therapy. 13: 2. PMID 33397464 DOI: 10.1186/s13195-020-00713-3 | ||
2021 | Habekost M, Qvist P, Denham M, Holm IE, Jørgensen AL. Directly Reprogrammed Neurons Express MAPT and APP Splice Variants Pertinent to Ageing and Neurodegeneration. Molecular Neurobiology. PMID 33415685 DOI: 10.1007/s12035-020-02258-w | ||
2021 | Raut S, Patel R, Al-Ahmad AJ. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro. Fluids and Barriers of the Cns. 18: 3. PMID 33413468 DOI: 10.1186/s12987-020-00235-y | ||
2021 | Rao SS, Lago L, Volitakis I, Shukla JJ, McColl G, Finkelstein DI, Adlard PA. Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33410108 DOI: 10.1007/s13311-020-00972-w | ||
2021 | Pons V, Lévesque P, Plante MM, Rivest S. Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer's disease. Alzheimer's Research & Therapy. 13: 8. PMID 33402196 DOI: 10.1186/s13195-020-00747-7 | ||
2021 | Cao S, Fisher DW, Rodriguez G, Yu T, Dong H. Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice. Journal of Neuroinflammation. 18: 10. PMID 33407625 DOI: 10.1186/s12974-020-02054-2 | ||
2021 | Wang P, Ye Y. Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex. Nature Communications. 12: 95. PMID 33398028 DOI: 10.1038/s41467-020-20322-w | ||
2021 | Jagust WJ, Landau SM, . Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease. Neurology. PMID 33408147 DOI: 10.1212/WNL.0000000000011524 | ||
2021 | Zeng L, Zhang D, Liu Q, Zhang J, Mu K, Gao X, Zhang K, Li H, Wang Q, Zheng Y, Mao S. Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus. Neuroscience. PMID 33412244 DOI: 10.1016/j.neuroscience.2020.12.026 | ||
2021 | Syeda T, Cannon JR. Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. Journal of Biochemical and Molecular Toxicology. e22694. PMID 33393683 DOI: 10.1002/jbt.22694 |